Form 4 for AROW ARROW FINANCIAL CORP
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-20 · accession 0001463247-24-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-22 | 2024-11-20 | AROW | O'Conor Raymond F | Dir | F - Tax | $32.39 | -1,992 | 39.7K | -5% | -$64.5K |
| DM | 2024-11-22 | 2024-11-20 | AROW | O'Conor Raymond F | Dir | M - OptEx | $27.41 | +2,355 | 40.8K | +6% | +$64.6K |
| DM | 2024-11-22 | 2024-11-20 | AROW | O'Conor Raymond F | Dir | M - OptEx | $0.00 | -2,355 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-20 | F | D | 979 | $32.39 | 39,859 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-20 | M | A | 1,195 | $27.47 | 40,691 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-20 | F | D | 1,013 | $32.39 | 39,678 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-20 | M | A | 1,160 | $27.35 | 40,838 | D | — | — | |
| 5 | Derivative | Director Stock Option (Right to Buy) | 2024-11-20 | M | D | 1,195 | $0.00 | 0 | D | $27.47 · — to 2028-01-31 | 1,195 Common Stock | (F1) The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on each of January 31, 2019; January 31, 2020; January 31, 2021; and January 31, 2022. |
| 6 | Derivative | Director Stock Option (Right to Buy) | 2024-11-20 | M | D | 1,160 | $0.00 | 0 | D | $27.35 · — to 2029-01-30 | 1,160 Common Stock | (F2) The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on each of January 30, 2020; January 30, 2021; January 30, 2022; and January 30, 2023. |